Review
doi: 10.1038/nn943.
Treatment of mood disorders
Affiliations
- PMID: 12403988
- DOI: 10.1038/nn943
Item in Clipboard
Review
Treatment of mood disorders
Nat Neurosci.
2002 Nov.
Abstract
Depression is a leading cause of morbidity and mortality, and its treatment includes a high percentage of the medications prescribed by physicians. Available antidepressant drugs are safe and effective, but less than half of all patients attain complete remission after therapy with a single antidepressant. Others exhibit partial, refractory or intolerant responses to treatment, emphasizing the need to discover new antidepressants. The mechanisms of action of available medications are directing the field toward new research avenues. This review highlights those areas we believe will influence the field and soon lead to better treatment.
Comment in
-
Financial disclosure for review authors.Nat Neurosci. 2003 Oct;6(10):997. doi: 10.1038/nn1003-997. Nat Neurosci. 2003. PMID: 14513027 No abstract available.
-
Editorial policies on financial disclosure.Nat Neurosci. 2003 Oct;6(10):999-1000; author reply 1000-1. doi: 10.1038/nn1003-999. Nat Neurosci. 2003. PMID: 14513028 No abstract available.
-
Editorial policies on financial disclosure.Nat Neurosci. 2003 Oct;6(10):1001. doi: 10.1038/nn1003-1001. Nat Neurosci. 2003. PMID: 14513030 No abstract available.
Similar articles
-
Models of antidepressant action.J Clin Psychiatry. 1999;60 Suppl 14:16-20; discussion 31-5. J Clin Psychiatry. 1999. PMID: 10408421 Review.
-
New approaches to antidepressant drug discovery: beyond monoamines.Nat Rev Neurosci. 2006 Feb;7(2):137-51. doi: 10.1038/nrn1846. Nat Rev Neurosci. 2006. PMID: 16429123 Review.
-
Molecular and cellular mechanisms of antidepressant drugs.Depress Anxiety. 1996-1997;4(4):153-9. doi: 10.1002/(SICI)1520-6394(1996)4:4<153::AID-DA1>3.0.CO;2-G. Depress Anxiety. 1996. PMID: 9166647 Review.
-
New directions in the development of antidepressants: the interface of neurobiology and psychiatry.Hum Psychopharmacol. 2002 Jun;17 Suppl 1:S13-6. doi: 10.1002/hup.396. Hum Psychopharmacol. 2002. PMID: 12404664 Review.
-
[Mechanism of action of antidepressants and therapeutic perspectives].Therapie. 2002 Jul-Aug;57(4):385-96. Therapie. 2002. PMID: 12422559 Review. French.
Cited by
-
Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.Adv Exp Med Biol. 2021;21:13-127. doi: 10.1007/5584_2020_584. Adv Exp Med Biol. 2021. PMID: 33052588 Review.
-
Gender-specific association of galanin polymorphisms with HPA-axis dysregulation, symptom severity, and antidepressant treatment response.Neuropsychopharmacology. 2010 Jun;35(7):1583-92. doi: 10.1038/npp.2010.30. Epub 2010 Mar 17. Neuropsychopharmacology. 2010. PMID: 20237460 Free PMC article.
-
Maternal deprivation induces depressive-like behaviour and alters neurotrophin levels in the rat brain.Neurochem Res. 2011 Mar;36(3):460-6. doi: 10.1007/s11064-010-0364-3. Epub 2010 Dec 16. Neurochem Res. 2011. PMID: 21161589
-
Melatonin Augments the Effects of Fluoxetine on Depression-Like Behavior and Hippocampal BDNF-TrkB Signaling.Neurosci Bull. 2018 Apr;34(2):303-311. doi: 10.1007/s12264-017-0189-z. Epub 2017 Oct 31. Neurosci Bull. 2018. PMID: 29086908 Free PMC article.
-
Somatic drugs for psychiatric diseases: aspirin or simvastatin for depression?Curr Neuropharmacol. 2012 Jun;10(2):139-58. doi: 10.2174/157015912800604533. Curr Neuropharmacol. 2012. PMID: 23204984 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
